105 related articles for article (PubMed ID: 12751735)
1. Cytochrome P450-derived eicosanoids mediators of ocular surface inflammation. are.
Laniado-Schwartzman M; Dunn MW
Adv Exp Med Biol; 2003; 525():47-54. PubMed ID: 12751735
[No Abstract] [Full Text] [Related]
2. Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium.
Vafeas C; Mieyal PA; Urbano F; Falck JR; Chauhan K; Berman M; Schwartzman ML
J Pharmacol Exp Ther; 1998 Dec; 287(3):903-10. PubMed ID: 9864271
[TBL] [Abstract][Full Text] [Related]
3. Induction of corneal epithelial cytochrome P-450 arachidonate metabolism by contact lens wear.
Davis KL; Conners MS; Dunn MW; Schwartzman ML
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):291-7. PubMed ID: 1740358
[TBL] [Abstract][Full Text] [Related]
4. The cytochrome P450 metabolic pathway of arachidonic acid in the cornea.
Schwartzman ML; Davis KL; Nishimura M; Abraham NG; Murphy RC
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():185-92. PubMed ID: 1847765
[No Abstract] [Full Text] [Related]
5. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
6. Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium.
Conners MS; Urbano F; Vafeas C; Stoltz RA; Dunn MW; Schwartzman ML
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1963-71. PubMed ID: 9331260
[TBL] [Abstract][Full Text] [Related]
7. Oxygenation of 5,8,11-eicosatrienoic acid by prostaglandin endoperoxide synthase and by cytochrome P450 monooxygenase: structure and mechanism of formation of major metabolites.
Oliw EH; Hörnsten L; Sprecher H; Hamberg M
Arch Biochem Biophys; 1993 Sep; 305(2):288-97. PubMed ID: 8373167
[TBL] [Abstract][Full Text] [Related]
8. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
9. To move or not to move? Cytochrome P450 products and cell migration.
Fleming I
Circ Res; 2002 May; 90(9):936-8. PubMed ID: 12016258
[No Abstract] [Full Text] [Related]
10. Novel eicosanoids generated by cytochrome P450: effects on platelet aggregation and protein phosphorylation.
Malcolm K; Falck JR; Fitzpatrick FA
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():87-94. PubMed ID: 2144702
[No Abstract] [Full Text] [Related]
11. A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae.
Conners MS; Stoltz RA; Davis KL; Dunn MW; Abraham NG; Levere RD; Laniado-Schwartzman M
Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):841-50. PubMed ID: 7706032
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450-derived eicosanoids and inflammation in liver diseases.
Shoieb SM; El-Ghiaty MA; Alqahtani MA; El-Kadi AOS
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106400. PubMed ID: 31733338
[TBL] [Abstract][Full Text] [Related]
13. The effect of hypoxia on endogenous corneal epithelial eicosanoids.
Mieyal PA; Bonazzi A; Jiang H; Dunn MW; Schwartzman ML
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2170-6. PubMed ID: 10892859
[TBL] [Abstract][Full Text] [Related]
14. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators.
Campbell WB
Trends Pharmacol Sci; 2000 Apr; 21(4):125-7. PubMed ID: 10740283
[No Abstract] [Full Text] [Related]
15. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
[TBL] [Abstract][Full Text] [Related]
16. A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome P450 arachidonic acid metabolites.
Conners MS; Stoltz RA; Webb SC; Rosenberg J; Dunn MW; Abraham NG; Laniado-Schwartzman M
Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):828-40. PubMed ID: 7706031
[TBL] [Abstract][Full Text] [Related]
17. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells.
Michaelis UR; Xia N; Barbosa-Sicard E; Falck JR; Fleming I
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1242-7. PubMed ID: 18326754
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Johnson AL; Edson KZ; Totah RA; Rettie AE
Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909
[TBL] [Abstract][Full Text] [Related]
20. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
